More threat to Gilead’s HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada aliu Mon, 05/18/2020 – […]
Researchers at the University of Eastern Finland have developed a new and promising drug compound for the treatment […]
For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM) has […]
“Healthcare staff should work together with patients and carers to educate the next generation of doctors, we’re on […]
Just 0.27% of people—one in 370—are estimated to have had covid-19 outside of hospitals and care homes in […]
Two tests for covid-19 antibodies have been assessed and validated by Public Health England (PHE), but experts have […]
As the UK moves beyond the first wave peak, the national conversation surrounding covid-19 has shifted to how […]
bmj;369/may18_2/m1988/FAF1faIt is hard to imagine how a consultant paediatrician from Basingstoke initially reacted to the horror of seeing […]
The guidelines should help healthcare professionals decide what care to provide for people without COVID-19 infection or with […]
ViiV said cabotegravir was found to be 69% more effective at preventing HIV acquisition than daily oral PrEP […]